Turpie, A., Mantovani, L., Haas, S., Kreutz, R., Monje, D., Schneider, J., et al. (2015). XALIA, a non-interventional study comparing rivaroxaban with standard anticoagulation for initial and long-term therapy in deep vein thrombosis: baseline demographics and hospitalizationrates. In Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015 (pp.727-727). WILEY-BLACKWELL [10.1111/jth.12993].

XALIA, a non-interventional study comparing rivaroxaban with standard anticoagulation for initial and long-term therapy in deep vein thrombosis: baseline demographics and hospitalizationrates

Mantovani, LG;
2015

abstract
Hematology
English
XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015
2015
Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015
2015
13
S2
727
727
PO607-TUE
https://www.sciencedirect.com/science/article/pii/S1538783622031336
none
Turpie, A., Mantovani, L., Haas, S., Kreutz, R., Monje, D., Schneider, J., et al. (2015). XALIA, a non-interventional study comparing rivaroxaban with standard anticoagulation for initial and long-term therapy in deep vein thrombosis: baseline demographics and hospitalizationrates. In Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015 (pp.727-727). WILEY-BLACKWELL [10.1111/jth.12993].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/620423
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact